Immunologic Research · 2020 · 17 citations · 28 references
MedicineImmunologyNephrologyClinical ImmunologyImmunopathologyRenal PathologyB-cell ResponsesImmune-mediated Renal DiseaseRenal DiseaseRenal ImmunopathologyRenal ImpairmentTubulointerstitial DiseasesB Cell-mediated Renal InjuryBiopsy In Igg4-related DiseaseEstimated Glomerular Filtration Rate DeclineIgg4-related Tubulointerstitial NephritisImmune-mediated NephritisImmune-mediated Tubulointerstitial NephritisImmunological ResponseTubulointerstitial Nephritis Syndrome
Abstract IgG4-related disease (IgG4-RD) is an immune-mediated disorder often showing elevated serum IgG4 concentrations, dense T and B lymphocyte infiltration, and IgG4-positive plasma cells and storiform fibrosis. We prospectively evaluated for 4 years 5 patients with histologically proven IgG4-RD of whom 3 had tubulointerstitial nephritis (TIN) and 2 had retroperitoneal fibrosis (RPF). They received an intensive B depletion therapy with rituximab. The estimated glomerular filtration rate of TIN patients after 1 year increased from 9 to 24 ml/min per 1.73 m2. IgG/IgG4 dropped from 3236/665 to 706/51 mg/dl, C3/C4 went up from 49/6 to 99/27 mg/dl, and the IgG4-RD responder index fell from 10 to 1. CD20 + B cells decreased from 8.7 to 0.5%. A striking drop in interstitial plasma cell infiltrate as well as normalization of IgG4/IgG-positive plasma cells was observed at repeat biopsy. Both clinical and immunological improvement persisted over a 4-year follow-up. Treating these patients who were affected by aggressive IgG4-RD with renal involvement in an effort to induce a prolonged B cells depletion with IgG4 and cytokine production decrease resulted in a considerable rise in eGFR, with IgG4-RD RI normalization and a noteworthy improvement in clinical and histological features. Furthermore, the TIN subgroup was shown not to need for any maintenance therapy.
28
John H. Stone, John K. C. Chan, Vikram Deshpande et al. · International Journal of Rheumatology · 2013 · 557 citations · Full text
Life Sciences, Immunology, Pathology +14